EDGAR Filing Documents for 0001477932-17-006280

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001477932-17-006280

Filing Date

2017-12-27

Accepted

2017-12-27 15:07:17

Documents

Period of Report

2017-12-22

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	form4.html	4
1	FORM 4	form4.xml	4	3034
	Complete submission text file	0001477932-17-006280.txt		4634

Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915

Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125

Innovation Pharmaceuticals Inc. (Issuer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INNOVATION PHARMACEUTICALS INC. 100 CUMMINGS CENTER, SUITE 151-B BEVERLY MA 01915

Business Address

Type: 4 | Act: 34 | File No.: 001-37357 | Film No.: 171276067